NO20004818D0 - Stabile doseringsformer av fluoxetin og dets enantiomere - Google Patents

Stabile doseringsformer av fluoxetin og dets enantiomere

Info

Publication number
NO20004818D0
NO20004818D0 NO20004818A NO20004818A NO20004818D0 NO 20004818 D0 NO20004818 D0 NO 20004818D0 NO 20004818 A NO20004818 A NO 20004818A NO 20004818 A NO20004818 A NO 20004818A NO 20004818 D0 NO20004818 D0 NO 20004818D0
Authority
NO
Norway
Prior art keywords
fluoxetine
enantiomers
dosage forms
stable dosage
stable
Prior art date
Application number
NO20004818A
Other languages
English (en)
Other versions
NO20004818L (no
Inventor
Martin P Redmon
Hal T Butler
Stephen A Wald
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO20004818D0 publication Critical patent/NO20004818D0/no
Publication of NO20004818L publication Critical patent/NO20004818L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20004818A 1998-03-27 2000-09-26 Stabile doseringsformer av fluoxetin og dets enantiomere NO20004818L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/049,227 US20030013740A1 (en) 1998-03-27 1998-03-27 Stable dosage forms of fluoxetine and its enantiomers
PCT/US1999/006601 WO1999049857A1 (en) 1998-03-27 1999-03-25 Stable dosage forms of fluoxetine and its enantiomers

Publications (2)

Publication Number Publication Date
NO20004818D0 true NO20004818D0 (no) 2000-09-26
NO20004818L NO20004818L (no) 2000-11-23

Family

ID=21958714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004818A NO20004818L (no) 1998-03-27 2000-09-26 Stabile doseringsformer av fluoxetin og dets enantiomere

Country Status (11)

Country Link
US (1) US20030013740A1 (no)
EP (1) EP1067918A1 (no)
JP (1) JP2002509882A (no)
KR (1) KR20010034703A (no)
CN (1) CN1303280A (no)
AU (1) AU3205399A (no)
BR (1) BR9909118A (no)
CA (1) CA2325858A1 (no)
NO (1) NO20004818L (no)
WO (1) WO1999049857A1 (no)
ZA (1) ZA200005189B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US6313350B1 (en) 2001-01-31 2001-11-06 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6310251B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6310250B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form A of fluoxetine hydrochloride
US6316672B1 (en) 2001-01-31 2001-11-13 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6258853B1 (en) 2001-01-31 2001-07-10 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CN109503584A (zh) 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA024980B1 (ru) 2009-02-17 2016-11-30 КРКА, д.д., НОВО МЕСТО Лекарственные формы, содержащие основание прасугреля или его фармацевтически приемлемые соли присоединения кислоты, и способы их приготовления
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP2790734B1 (en) 2011-12-15 2019-02-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
MX378004B (es) * 2015-12-02 2025-03-10 Jaime Samuel CHAIT AUERBACH Composición oral veterinaria con gabapentina.
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
CN107334744B (zh) * 2017-07-24 2020-09-04 湖南洞庭药业股份有限公司 盐酸美金刚药物组合物和制法
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594358A (en) * 1985-02-25 1986-06-10 Eli Lilly And Company Analgesic method
CH678920A5 (no) * 1989-11-14 1991-11-29 Gergely Gerhard
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
AU1729297A (en) * 1996-02-09 1997-08-28 Quadrant Holdings Cambridge Limited Solid formulations containing trehalose
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders
CA2175939C (en) * 1996-05-07 1999-09-14 Michael Warnett Hetherington Manual capsule filling device
DE69735656T2 (de) * 1996-07-15 2006-08-24 Alza Corp., Mountain View Vorrichtung zur transdermalen Verabreichung von Fluoxetin
US5830500A (en) * 1996-07-22 1998-11-03 Pentech Pharmaceuticals, Inc. Low dose fluoxetine tablet

Also Published As

Publication number Publication date
AU3205399A (en) 1999-10-18
ZA200005189B (en) 2001-05-22
JP2002509882A (ja) 2002-04-02
US20030013740A1 (en) 2003-01-16
BR9909118A (pt) 2001-10-16
CN1303280A (zh) 2001-07-11
KR20010034703A (ko) 2001-04-25
EP1067918A1 (en) 2001-01-17
WO1999049857A1 (en) 1999-10-07
NO20004818L (no) 2000-11-23
CA2325858A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
NO20004818D0 (no) Stabile doseringsformer av fluoxetin og dets enantiomere
CY2006003I1 (el) Χρηση δαπτομυκινης
DK1210943T3 (da) Ny anvendelse af budesonid og formoterol
IS2325B (is) Örgerðar samsetningar epleróns
DK1033996T3 (da) Forebyggelse og behandling af amyloidogen sygdom
CY2012029I1 (el) Νεα μορφη της s-ομεπραζολης
ID27092A (id) Pembuatan ftalat anhidrida
PT1100459E (pt) Preparacao oleosa espumante e sua utilizacao
NO20010446D0 (no) Substituert anilidforbindelser og metoder
EP1423399A4 (en) HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATIZING AGENTS
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20006488D0 (no) Sammensetning og anvendelse
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
EP1045689A4 (en) SYNTHESIS OF PHENSTATIN AND ITS PRODUCTS
DE60036093D1 (de) Antagonisten des gardos-kanals
NO20012011D0 (no) Fremstilling og anvendelse av stivnede oljer
IS6135A (is) Samsett forlyf af amlódipíni og atorvastatíni
EE200200654A (et) Bikalutamiidi ja tamoksifeeni farmatseutiline kombinatsioon antiandrogeense toime ja antiöstrogeense toime saavutamiseks
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
DE59911099D1 (de) Stabile mitoxantron-lösungen
EE200100084A (xx) NOS inhibiitorite uued farmatseutilised kasutusv�imalused
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20033743L (no) Fremgangsmåte og fremstilling citalopram
ITBO20000510A0 (it) Apparecchiatura e metodo per la realizzazione di tracheostomia